Glucagonoma Pancreatic Neuroendocrine Tumor Treated With 177Lu DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy

被引：11
|
作者：
Makis, William [1 ]
McCann, Karey [1 ]
Riauka, Terence A. [1 ]
McEwan, Alexander J. B. [1 ]
机构：
[1] Cross Canc Inst, Dept Diagnost Imaging, Edmonton, AB T6G 1Z2, Canada
来源：
CLINICAL NUCLEAR MEDICINE | 2015年 / 40卷 / 11期
关键词：
PRRT; Lu-177; DOTATATE; lutetium; glucagonoma; necrolytic migratory erythema;
D O I：
10.1097/RLU.0000000000000891
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 56-year-old man presented with a history of 2 prior resections of a recurrent pancreatic glucagonoma in the past 4 years. Workup revealed new liver and abdominal nodal metastases with a rising serum glucagon level. He was started on peptide receptor radionuclide therapy with Lu-177 DOTATATE, and his disease stabilized, while his glucagon levels decreased and also stabilized. After 4 induction and 2 maintenance cycles, he remains progression free for 23 months.
引用
收藏
页码：877 / 879
页数：3
相关论文
共 50 条
  • [21] Extraventricular Neurocytoma Treated With 177Lu DOTATATE PRRT Induction and Maintenance Therapies
    Makis, William
    McCann, Karey
    McEwan, Alexander J. B.
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (03) : 234 - 236
  • [22] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Peter Frøhlich Staanum
    Anders Floor Frellsen
    Marie Louise Olesen
    Peter Iversen
    Anne Kirstine Arveschoug
    [J]. EJNMMI Physics, 8
  • [23] Practical kidney dosimetry in peptide receptor radionuclide therapy using [177Lu]Lu-DOTATOC and [177Lu]Lu-DOTATATE with focus on uncertainty estimates
    Staanum, Peter Frohlich
    Frellsen, Anders Floor
    Olesen, Marie Louise
    Iversen, Peter
    Arveschoug, Anne Kirstine
    [J]. EJNMMI PHYSICS, 2021, 8 (01)
  • [24] Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE
    Prado-Wohlwend, S.
    Bernal-Vergara, J. C.
    Utrera-Costero, A.
    Canon-Sanchez, J. R.
    Agudelo-Cifuentes, M.
    Bello-Arques, P.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2022, 41 (01): : 55 - 65
  • [25] Management of a Patient With Metastatic Gastrointestinal Neuroendocrine Tumor and Meningioma Submitted to Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE
    Pirisino, Riccardo
    Filippi, Luca
    D'Agostini, Antonio
    Bagni, Oreste
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (11) : E692 - E695
  • [26] Peptide Receptor Radionuclide Therapy With 177Lu DOTATATE in a Case of Recurrent Carotid Body Paraganglioma With Spinal Metastases
    Gupta, Santosh Kumar
    Singla, Suhas
    Karunanithi, Sellam
    Damle, Nishikant
    Bal, Chandrasekhar
    [J]. CLINICAL NUCLEAR MEDICINE, 2014, 39 (05) : 440 - 441
  • [27] 177Lu Dotatate Peptide Receptor Radionuclide Therapy in Chronic Kidney Disease Patients: A Single Center Experience
    Manohar, Sandhya
    Kompotiatis, Panagiotis
    Halfdanarson, Thorvardur R.
    Hobday, Timothy J.
    Thorpe, Matthew
    Johnson, Geoffrey B.
    Kendi, Ayse T.
    Leung, Nelson
    [J]. PANCREAS, 2022, 51 (03) : E45 - E46
  • [28] Efficacy of 177Lu Peptide Receptor Radionuclide Therapy for the Treatment of Neuroendocrine Tumors A Meta-analysis
    Saravana-Bawan, Bianka
    Bajwa, Amandeep
    Paterson, John
    McEwan, Alexander J. B.
    McMullen, Todd P. W.
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 719 - 727
  • [29] Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors
    Abou Jokh Casas, E.
    Pombo Pasin, M. D.
    Pubul Nunez, V.
    Garrido Pumar, M.
    Blanco Freire, M. N.
    Cabezas, J.
    Cameselle, J.
    Berrios, M.
    Argibay, S.
    Ruibal Morell, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S597 - S598
  • [30] 177Lu-Dotatate Peptide Receptor Radionuclide Therapy Dose Response in Small Intestinal Neuroendocrine Tumors
    Jahn, U. M. M.
    Ilan, E.
    Sandstrom, M.
    Bamerny, M.
    Garske-Roman, U.
    Lubberink, M.
    Sundin, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S157 - S158
12345